Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT200000201ApriorityCriticalpatent/GT200000201A/en
Publication of GT200000201ApublicationCriticalpatent/GT200000201A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
EL INVENTO SE REFIERE A UNA COMPOSICION FARMACEUTICA CONVENIENTE PARA EL TRATAMIENTO DE ENFERMEDADES VIRALES, COMO POR EJEMPLO INFECCIONES VIRALES EN HUMANOS, O PARA PREVENIR ESTOS PROBLEMAS, LA COMPOSICION CONTIENE COMO AGENTE ACTIVO EL COMPUESTO INDICADO POR LA ESTRUCTURA I & II EN LA CUAL LAS LETRAS R= OH, Y LOS OTROS SIMBOLOS RESTANTES REPRESENTAN H. ESTA COMPOSICION COMBINA UNA ACCION INMEDIATA CONTRA VIRUS O UN TRATAMIENTO INMEDIATO PARA LOS PROBLEMAS DEL HIGADO Y DE ALGUNA FORMA RETARDA LA ACCION O TRATAMIENTO.THE INVENTION REFERS TO A CONVENIENT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES, AS FOR EXAMPLE VIRAL INFECTIONS IN HUMANS, OR TO PREVENT THESE PROBLEMS, THE COMPOSITION CONTAINS AS ACTIVE AGENT THE COMPOUND INDICATED BY THE STRUCTURE I & II R = OH, AND THE OTHER REMAINING SYMBOLS REPRESENT H. THIS COMPOSITION COMBINES AN IMMEDIATE ACTION AGAINST VIRUSES OR IMMEDIATE TREATMENT FOR THE PROBLEMS OF THE LIVER AND IN ANY FORM DELAYS THE ACTION OR TREATMENT.
METHOD TO TREAT OR PREVENT INFECTION CAUSED BY MICROBES, COMPOSITION FOR THE SAME AND METHODS TO DISINFECT DEVICES AND TO PREVENT INFECTIONS ORIGINATED IN MEDICAL DEVICES
Crystalline forms of a compound derived from 2-thiazolyl-4-quinolinyl-oxy; Sodium salt of the compound, pharmaceutical composition comprising sodium salt, useful for treating hepatitis C virus infection.
ANTRANILAMIDS WITH A SIDE CHAIN OF A HETEROARYLSULFONIL, METHODS FOR THE PRODUCTION OF THE SAME, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AND PHARMACEUTICAL PREPARATIONS CONTAINED IN SUCH COMPOUNDS
COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE TO TREAT OR PREVENT INFECTION OF HEPATITIS C.
Vesicular formulation comprising one or more phospholipids and one or more non-ionic surfactants, free of any pharmaceutically active agent, useful for the treatment of pain associated with osteoarthritis.